Suzhou Abogen Biosciences has raised as much as 600-million yuan ($92 million) in its Series B round of funding to expand its operation, per an announcement.
The fresh round was jointly led by state-owned investment entities PICC Capital, and SDIC Venture Capital Management, besides YF Capital, a PE firm co-founded by Alibaba’s Jack Ma in 2010.
